JACOBS LEVY EQUITY MANAGEMENT, INC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 90 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$253,950
-86.8%
37,903
-87.2%
0.00%
-91.7%
Q1 2023$1,922,214
-24.5%
295,271
-1.1%
0.01%
-29.4%
Q4 2022$2,547,195
+7.0%
298,616
-33.8%
0.02%
-10.5%
Q3 2022$2,380,000450,8340.02%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$26,123,9999.73%
Nextech Invest Ltd. 1,910,029$12,434,2895.19%
K2 PRINCIPAL FUND, L.P. 2,686,490$17,489,0512.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$72,117,3051.61%
Orbimed Advisors 8,740,887$56,903,1741.12%
SECTORAL ASSET MANAGEMENT INC 793,587$5,166,2510.99%
Tejara Capital Ltd 207,555$1,351,1830.69%
Rubric Capital Management LP 3,480,712$22,659,4350.59%
Resolute Capital Asset Partners LLC 120,000$7810.57%
RA Capital Management 3,009,678$19,593,0040.44%
View complete list of SILVERBACK THERAPEUTICS INC shareholders